Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1990 Jun 1;171(6):2101–2114. doi: 10.1084/jem.171.6.2101

Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis

PMCID: PMC2187943  PMID: 2351933

Abstract

We have examined the hypothesis that MHC ancestral haplotypes have a specific content of genes regulating the extent of autoimmune reactions. Gene copy number was quantitated by objective densitometry after PFGE was used to separate heterozygous AHs of different lengths. Initially we analyzed examples of known gene copy number at the C4 and 21 hydroxylase loci and showed that the approach provides predictable results. We then studied heterozygotes containing one characterized and one uncharacterized AH with particular attention to the gene copy number at the C4, Cyp21, and DRB loci. Each AH studied has a characteristic gene copy number at each locus studied. The same may be true of TNF, but other possibilities must be considered. AHs are markers for extensive chromosomal segments including particular numbers of several functional genes. Since AHs mark susceptibility to autoimmune disease, differences in gene copy number may be implicated.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awdeh Z. L., Raum D., Yunis E. J., Alper C. A. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci U S A. 1983 Jan;80(1):259–263. doi: 10.1073/pnas.80.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Belt K. T., Carroll M. C., Porter R. R. The structural basis of the multiple forms of human complement component C4. Cell. 1984 Apr;36(4):907–914. doi: 10.1016/0092-8674(84)90040-0. [DOI] [PubMed] [Google Scholar]
  3. Bendtzen K., Morling N., Fomsgaard A., Svenson M., Jakobsen B., Odum N., Svejgaard A. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol. 1988 Nov;28(5):599–606. doi: 10.1111/j.1365-3083.1988.tb01492.x. [DOI] [PubMed] [Google Scholar]
  4. Böhme J., Andersson M., Andersson G., Möller E., Peterson P. A., Rask L. HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. J Immunol. 1985 Sep;135(3):2149–2155. [PubMed] [Google Scholar]
  5. Campbell R. D., Bentley D. R., Morley B. J. The factor B and C2 genes. Philos Trans R Soc Lond B Biol Sci. 1984 Sep 6;306(1129):367–378. doi: 10.1098/rstb.1984.0097. [DOI] [PubMed] [Google Scholar]
  6. Carroll M. C., Palsdottir A., Belt K. T., Yu C. Y. Molecular genetics of the fourth component of human complement. Biochem Soc Symp. 1986;51:29–36. [PubMed] [Google Scholar]
  7. Cerami A., Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today. 1988 Jan;9(1):28–31. doi: 10.1016/0167-5699(88)91353-9. [DOI] [PubMed] [Google Scholar]
  8. Christiansen F. T., Dawkins R. L., Uko G., McCluskey J., Kay P. H., Zilko P. J. Complement allotyping in SLE: association with C4A null. Aust N Z J Med. 1983 Oct;13(5):483–488. doi: 10.1111/j.1445-5994.1983.tb02699.x. [DOI] [PubMed] [Google Scholar]
  9. Collier S., Sinnott P. J., Dyer P. A., Price D. A., Harris R., Strachan T. Pulsed field gel electrophoresis identifies a high degree of variability in the number of tandem 21-hydroxylase and complement C4 gene repeats in 21-hydroxylase deficiency haplotypes. EMBO J. 1989 May;8(5):1393–1402. doi: 10.1002/j.1460-2075.1989.tb03520.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dawkins R. L., Leaver A., Cameron P. U., Martin E., Kay P. H., Christiansen F. T. Some disease-associated ancestral haplotypes carry a polymorphism of TNF. Hum Immunol. 1989 Oct;26(2):91–97. doi: 10.1016/0198-8859(89)90094-3. [DOI] [PubMed] [Google Scholar]
  11. Dawkins R. L., Martin E., Kay P. H., Garlepp M. J., Wilton A. N., Stuckey M. S. Heterogeneity of steroid 21-hydroxylase genes in classical congenital adrenal hyperplasia. J Immunogenet. 1987 Apr-Jun;14(2-3):89–98. doi: 10.1111/j.1744-313x.1987.tb00367.x. [DOI] [PubMed] [Google Scholar]
  12. Dupont B., Oberfield S. E., Smithwick E. M., Lee T. D., Levine L. S. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet. 1977 Dec 24;2(8052-8053):1309–1312. doi: 10.1016/s0140-6736(77)90362-2. [DOI] [PubMed] [Google Scholar]
  13. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  14. Flaherty L. Major histocompatibility complex polymorphism: a nonimmune theory for selection. Hum Immunol. 1988 Jan;21(1):3–13. doi: 10.1016/0198-8859(88)90076-6. [DOI] [PubMed] [Google Scholar]
  15. Garlepp M. J., Wilton A. N., Dawkins R. L., White P. C. Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics. 1986;23(2):100–105. doi: 10.1007/BF00377968. [DOI] [PubMed] [Google Scholar]
  16. Gordon C., Ranges G. E., Greenspan J. S., Wofsy D. Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol. 1989 Sep;52(3):421–434. doi: 10.1016/0090-1229(89)90157-8. [DOI] [PubMed] [Google Scholar]
  17. Hongming F., Tilanus M., van Eggermond M., Giphart M. Reduced complexity of RFLP for HLA-DR typing by the use of a DR beta 3' cDNA probe. Tissue Antigens. 1986 Sep;28(3):129–135. doi: 10.1111/j.1399-0039.1986.tb00472.x. [DOI] [PubMed] [Google Scholar]
  18. Jacob C. O., McDevitt H. O. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature. 1988 Jan 28;331(6154):356–358. doi: 10.1038/331356a0. [DOI] [PubMed] [Google Scholar]
  19. Kehrl J. H., Miller A., Fauci A. S. Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J Exp Med. 1987 Sep 1;166(3):786–791. doi: 10.1084/jem.166.3.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kelly H., McCann V. J., Kay P. H., Dawkins R. L. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles. Immunogenetics. 1985;22(6):643–651. doi: 10.1007/BF00430313. [DOI] [PubMed] [Google Scholar]
  21. Kramer J., Gyódi E., Füst G. Usefulness of densitometry in typing of human complement component C4. Immunogenetics. 1989;29(2):121–123. doi: 10.1007/BF00395861. [DOI] [PubMed] [Google Scholar]
  22. Long E. O., Wake C. T., Gorski J., Mach B. Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes. EMBO J. 1983;2(3):389–394. doi: 10.1002/j.1460-2075.1983.tb01435.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Morel Y., Bristow J., Gitelman S. E., Miller W. L. Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6582–6586. doi: 10.1073/pnas.86.17.6582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Morley B. J., Campbell R. D. Internal homologies of the Ba fragment from human complement component Factor B, a class III MHC antigen. EMBO J. 1984 Jan;3(1):153–157. doi: 10.1002/j.1460-2075.1984.tb01776.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mølvig J., Baek L., Christensen P., Manogue K. R., Vlassara H., Platz P., Nielsen L. S., Svejgaard A., Nerup J. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol. 1988 Jun;27(6):705–716. doi: 10.1111/j.1365-3083.1988.tb02404.x. [DOI] [PubMed] [Google Scholar]
  26. Nedwin G. E., Naylor S. L., Sakaguchi A. Y., Smith D., Jarrett-Nedwin J., Pennica D., Goeddel D. V., Gray P. W. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 1985 Sep 11;13(17):6361–6373. doi: 10.1093/nar/13.17.6361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pennica D., Nedwin G. E., Hayflick J. S., Seeburg P. H., Derynck R., Palladino M. A., Kohr W. J., Aggarwal B. B., Goeddel D. V. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984 Dec 20;312(5996):724–729. doi: 10.1038/312724a0. [DOI] [PubMed] [Google Scholar]
  28. Reed K. C., Mann D. A. Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res. 1985 Oct 25;13(20):7207–7221. doi: 10.1093/nar/13.20.7207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Santamaria P., Gehrz R. C., Bryan M. K., Barbosa J. J. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level. J Immunol. 1989 Aug 1;143(3):913–922. [PubMed] [Google Scholar]
  30. Schneider P. M., Carroll M. C., Alper C. A., Rittner C., Whitehead A. S., Yunis E. J., Colten H. R. Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest. 1986 Sep;78(3):650–657. doi: 10.1172/JCI112623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sim E., Cross S. J. Phenotyping of human complement component C4, a class-III HLA antigen. Biochem J. 1986 Nov 1;239(3):763–767. doi: 10.1042/bj2390763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Southern E. M., Anand R., Brown W. R., Fletcher D. S. A model for the separation of large DNA molecules by crossed field gel electrophoresis. Nucleic Acids Res. 1987 Aug 11;15(15):5925–5943. doi: 10.1093/nar/15.15.5925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sutton V. R., Knowles R. W. Mapping of a restriction fragment length polymorphism associated with defective DR beta 4 chain expression to the HLA-DRB1 gene. Hum Immunol. 1988 Jun;22(2):123–134. doi: 10.1016/0198-8859(88)90042-0. [DOI] [PubMed] [Google Scholar]
  34. Teisberg P., Jonassen R., Mevåg B., Gedde-Dahl T., Jr, Olaisen B. Restriction fragment length polymorphisms of the complement component C4 loci on chromosome 6: studies with emphasis on the determination of gene number. Ann Hum Genet. 1988 May;52(Pt 2):77–84. doi: 10.1111/j.1469-1809.1988.tb01082.x. [DOI] [PubMed] [Google Scholar]
  35. Tokunaga K., Saueracker G., Kay P. H., Christiansen F. T., Anand R., Dawkins R. L. Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis. J Exp Med. 1988 Sep 1;168(3):933–940. doi: 10.1084/jem.168.3.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Uring-Lambert B., Mascart-Lemone F., Tongio M. M., Goetz J., Hauptmann G. Molecular basis of complete C4 deficiency. A study of three patients. Hum Immunol. 1989 Feb;24(2):125–132. doi: 10.1016/0198-8859(89)90052-9. [DOI] [PubMed] [Google Scholar]
  37. White P. C., New M. I., Dupont B. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5111–5115. doi: 10.1073/pnas.83.14.5111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wilton A. N., Cobain T. J., Dawkins R. L. Family studies of IgA deficiency. Immunogenetics. 1985;21(4):333–342. doi: 10.1007/BF00430799. [DOI] [PubMed] [Google Scholar]
  39. Zhang W. J., Kay P. H., Cobain T. J., Dawkins R. L. C4 allotyping on plasma or serum: application to routine laboratories. Hum Immunol. 1988 Mar;21(3):165–171. doi: 10.1016/0198-8859(88)90068-7. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES